Literature DB >> 25590439

PCTAIRE1/PCTK1/CDK16: a new oncotarget?

Teruki Yanagi1, Shu-ichi Matsuzawa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25590439      PMCID： PMC4347670          DOI： 10.1080/15384101.2015.1006539

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  6 in total

Review 1.  PCTK proteins: the forgotten brain kinases?

Authors:  Adam R Cole
Journal:  Neurosignals       Date:  2009-09-30

2.  Two cyclin-dependent kinase pathways are essential for polarized trafficking of presynaptic components.

Authors:  Chan-Yen Ou; Vivian Y Poon; Celine I Maeder; Shigeki Watanabe; Emily K Lehrman; Amy K Y Fu; Mikyoung Park; Wing-Yu Fu; Erik M Jorgensen; Nancy Y Ip; Kang Shen
Journal:  Cell       Date:  2010-05-28       Impact factor: 41.582

Review 3.  The Cdk inhibitor p27 in human cancer: prognostic potential and relevance to anticancer therapy.

Authors:  Isabel M Chu; Ludger Hengst; Joyce M Slingerland
Journal:  Nat Rev Cancer       Date:  2008-04       Impact factor: 60.716

4.  PCTAIRE1 phosphorylates p27 and regulates mitosis in cancer cells.

Authors:  Teruki Yanagi; Maryla Krajewska; Shu-ichi Matsuzawa; John C Reed
Journal:  Cancer Res       Date:  2014-09-09       Impact factor: 12.701

5.  PCTAIRE1 regulates p27 stability, apoptosis and tumor growth in malignant melanoma.

Authors:  Teruki Yanagi; John C Reed; Shu-Ichi Matsuzawa
Journal:  Oncoscience       Date:  2014-10-05

Review 6.  Orphan kinases turn eccentric: a new class of cyclin Y-activated, membrane-targeted CDKs.

Authors:  Petra Mikolcevic; Johannes Rainer; Stephan Geley
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534
  6 in total
  17 in total

1.  Phospholipase Cβ1 regulates proliferation of neuronal cells.

Authors:  Osama Garwain; Kaitlyn Valla; Suzanne Scarlata
Journal:  FASEB J       Date:  2018-01-12       Impact factor: 5.191

2.  The role of phospholipase Cβ on the plasma membrane and in the cytosol: How modular domains enable novel functions.

Authors:  Suzanne Scarlata
Journal:  Adv Biol Regul       Date:  2019-07-29

Review 3.  Phospholipase Cβ interacts with cytosolic partners to regulate cell proliferation.

Authors:  Suzanne Scarlata; Ashima Singla; Osama Garwain
Journal:  Adv Biol Regul       Date:  2017-09-09

Review 4.  Regulation of bifunctional proteins in cells: Lessons from the phospholipase Cβ/G protein pathway.

Authors:  Lela Jackson; Androniqi Qifti; Katherine M Pearce; Suzanne Scarlata
Journal:  Protein Sci       Date:  2019-12-31       Impact factor: 6.725

5.  RNA Sequencing of Peripheral Blood Revealed that the Neurotropic TRK Receptor Signaling Pathway Shows Apparent Correlation in Recovery Following Spinal Cord Injury at Small Cohort.

Authors:  Chunqing Wang; Hangzhou Lv; Qing Li; Ke Gong; Lei Luo Yang; Zean Wei; Yujie Pan; Mingyong Wang
Journal:  J Mol Neurosci       Date:  2019-04-16       Impact factor: 3.444

Review 6.  Inhibitors of cyclin-dependent kinases as cancer therapeutics.

Authors:  Steven R Whittaker; Aurélie Mallinger; Paul Workman; Paul A Clarke
Journal:  Pharmacol Ther       Date:  2017-02-05       Impact factor: 12.310

7.  Role of downregulated miR-133a-3p expression in bladder cancer: a bioinformatics study.

Authors:  Li Gao; Sheng-Hua Li; Yi-Xin Tian; Qing-Qing Zhu; Gang Chen; Yu-Yan Pang; Xiao-Hua Hu
Journal:  Onco Targets Ther       Date:  2017-07-20       Impact factor: 4.147

8.  Structure and inhibitor specificity of the PCTAIRE-family kinase CDK16.

Authors:  Sarah E Dixon-Clarke; Saifeldin N Shehata; Tobias Krojer; Timothy D Sharpe; Frank von Delft; Kei Sakamoto; Alex N Bullock
Journal:  Biochem J       Date:  2017-02-20       Impact factor: 3.857

9.  Lipid Nanoparticle-mediated siRNA Transfer Against PCTAIRE1/PCTK1/Cdk16 Inhibits In Vivo Cancer Growth.

Authors:  Teruki Yanagi; Kiyoshi Tachikawa; Rachel Wilkie-Grantham; Asami Hishiki; Ko Nagai; Ellen Toyonaga; Pad Chivukula; Shu-Ichi Matsuzawa
Journal:  Mol Ther Nucleic Acids       Date:  2016-06-28       Impact factor: 10.183

10.  CDK16 Phosphorylates and Degrades p53 to Promote Radioresistance and Predicts Prognosis in Lung Cancer.

Authors:  Jie Xie; Yan Li; Ke Jiang; Kaishun Hu; Sheng Zhang; Xiaorong Dong; Xiaofang Dai; Li Liu; Tao Zhang; Kunyu Yang; Kai Huang; Junjie Chen; Shaojun Shi; Yu Zhang; Gang Wu; Shuangbing Xu
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.